(Reuters) -The U.S. Food and Drug Administration announced approval of leucovorin, or folinic acid, that U.S. President Donald Trump was slated to suggest as a treatment for autism symptoms at a White House event on Monday. The FDA published a notice in the Federal Register.

A Trump administration decision to repurpose an old chemotherapy drug for autism has surprised many experts — including the physician who recently proposed the idea. Dr.

The administration says Tylenol causes autism — but experts tell PEOPLE it has an "impressive" safety record for use during pregnancy.

Calling Democrats “deranged,” Trump claimed they “want to destroy healthcare in America by giving it to millions and millions of illegal aliens, referring to Democrats’ proposal to undo provisions of Trump’s signature policy bill passed earlier this year that would block some noncitizens from public health benefits, according to Politico.

President Donald Trump is aiming to ramp up scrutiny on pharmaceutical ads — both on TV and social media — as his administration accuses companies of misleading the public about medications and their side effects.

Some parents have reported positive changes in their kids after giving them the drug, but experts remain concerned about a lack of strong evidence.